Cather, J.C.
108  Ergebnisse:
Personensuche X
?
1

Safety of selective IL‐23p19 inhibitors for the treatment o..:

Crowley, J.J. ; Warren, R.B. ; Cather, J.C.
Journal of the European Academy of Dermatology and Venereology.  33 (2019)  9 - p. 1676-1684 , 2019
 
?
2

Ixekizumab efficacy and safety in moderate-to-severe genita..:

Ryan, C. ; Menter, A. ; Guenther, L....
British Journal of Dermatology.  179 (2018)  4 - p. e177-e177 , 2018
 
?
3

伊赛珠单抗在中度至重度生殖器银屑病中的疗效和安全性:

Ryan, C. ; Menter, A. ; Guenther, L....
British Journal of Dermatology.  179 (2018)  4 - p. e189-e189 , 2018
 
?
4

Efficacy and safety of ixekizumab in a randomized, double-b..:

Ryan, C. ; Menter, A. ; Guenther, L....
British Journal of Dermatology.  179 (2018)  4 - p. 844-852 , 2018
 
?
5

203 Patients' Perspectives on the Impact of Moderate-to-Sev..:

Cather, J.C. ; Potts Bleakman, A.P. ; Naegeli, A....
The Journal of Sexual Medicine.  15 (2018)  Supplement_1 - p. S65-S66 , 2018
 
?
6

Impact of ixekizumab treatment on skin‐related personal rel..:

Guenther, L. ; Warren, R.B. ; Cather, J.C....
Journal of the European Academy of Dermatology and Venereology.  31 (2017)  11 - p. 1867-1875 , 2017
 
?
 
?
8

A double‐blind, placebo‐controlled trial of rosiglitazone f..:

Henderson, D. C. ; Fan, X. ; Sharma, B....
Acta Psychiatrica Scandinavica.  119 (2009)  6 - p. 457-465 , 2009
 
?
9

Once-weekly d-cycloserine effects on negative symptoms and ..:

GOFF, D ; CATHER, C ; GOTTLIEB, J...
Schizophrenia Research.  106 (2008)  2-3 - p. 320-327 , 2008
 
?
10

A double‐blind, placebo‐controlled trial of sibutramine for..:

Henderson, D. C. ; Fan, X. ; Copeland, P. M....
Acta Psychiatrica Scandinavica.  115 (2006)  2 - p. 101-105 , 2006
 
?
 
?
12

An exploratory open‐label trial of aripiprazole as an adjuv..:

Henderson, D. C. ; Kunkel, L. ; Nguyen, D. D....
Acta Psychiatrica Scandinavica.  113 (2005)  2 - p. 142-147 , 2005
 
?
 
?
15

Adalimumab for Psoriasis:

, In: Advances in Psoriasis,
Tye, Cooper B. ; Cather, Jennifer C. - p. 153-172 , 2020
 
1-15